New Guidelines Issued for Management of IBS

Related Encyclopedia • Abdominoplasty • Acidophilus • Adhesions • Amebiasis More... Related Healthscout Videos Recipe for a Healthy Holiday Hungry Heart Natural Intelligence? Heavy Weight Battle More... Related Animations • GERD • PPI Therapy More... Related Drug Information • Aciphex • Klor-Con • Klor-Con ER • Nexium More... Related News Articles • Health Tip: Warning Signs of Binge Eating Disorder • Spice Compounds May Stem Tumor Growth • Menopause Often Means Worsening Cholesterol • Health Tip: Understanding Crohn's Disease More...

Page:  << Prev | 1 | 2 | 3

Though comprehensive, the guidelines were criticized for not explaining what outside funding was used for in the development process. The document does disclose that support was received from Takeda Pharmaceutical Co. and Salix Pharmaceuticals, which make products targeted to IBS.

Dr. Mark Ebell, deputy editor of American Family Physician, said he would feel more comfortable if the guidelines had been "very clear about what support was provided and what they needed the support for: paying for literature searches, for staff. … It's common to have support for guidelines. … I think it's generally unintentional, but when we have a relationship, it creates the potential for problems."

Ebell said that Brandt had relationships with pharmaceutical companies.

Text Continues Below

---

Brandt had a different view. "I don't have any ties to industry that would have any relevance to this publication," he said. "I don't receive money directly from any company. I own no stock and, nor does my family, so this is a totally unbiased thing. I have no conflict of interest whatsoever, and I think that does it."

Anne-Louise B. Oliphant, a spokeswoman for the American College of Gastroenterology, said: "No company was involved in any way in either structuring or completing the meta-analysis that forms the basis for the College's evidence-based recommendations on IBS. Furthermore, no company was in any way involved in deciding who served on the task force or in any of its work."

More information

To learn more about IBS, visit the U.S. National Institute of Diabetes and Digestive and Kidney Diseases online.

Page:  << Prev | 1 | 2 | 3